Regulatory B cells producing IL‐10 are increased in human tumor draining lymph nodes
International Journal of Cancer · 2023-08-15 · 153 (4) · 854-866
DOI: 10.1002/ijc.34555 ↗At a glance
Journal article in International Journal of Cancer, published online on 2023-05-05. Written by Krzysztof Piersiala and 11 co-authors. Institution: Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. Major MEDLINE topics: Carcinoma, Squamous Cell, B-Lymphocytes, Regulatory, Mouth Neoplasms. Cited 20 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Cancerfonden, Radiumhemmets Forskningsfonder.
Abstract (original language)
The contribution of different immune cell subsets, especially T cells, in anti‐tumor immune response is well established. In contrast to T cells, the anti‐tumor contribution of B cells has been scarcely investigated. B‐cells are often overlooked, even though they are important players in a fully integrated immune response and constitute a substantial fraction of tumor draining lymph nodes (TDLNs) known also as Sentinel Nodes. In this project, samples including TDLNs, non‐TDLNs (nTDLNs) and metastatic lymph nodes from 21 patients with oral squamous cell carcinoma were analyzed by flow cytometry. TDLNs were characterized by a significantly higher proportion of B cells compared with nTDLNs ( P = .0127). TDLNs‐associated B cells contained high percentages of naïve B cells, in contrary to nTDLNs which contained significantly higher percentages of memory B cells. Patients having metastases in TDLNs showed a significantly higher presence of immunosuppressive B regulatory cells compared with metastasis‐free patients ( P = .0008). Elevated levels of regulatory B cells in TDLNs were associated with the advancement of the disease. B cells in TDLNs were characterized by significantly higher expression of an immunosuppressive cytokine—IL‐10 compared with nTDLNs ( P = .0077). Our data indicate that B cells in human TDLNs differ from B cells in nTDLNs and exhibit more naïve and immunosuppressive phenotypes. We identified a high accumulation of regulatory B cells within TDLNs which may be a potential obstacle in achieving response to novel cancer immunotherapies (ICIs) in head and neck cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
- Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
- Medical unit Head Neck, Lung and skin Cancer, Karolinska University Hospital, Stockholm, Sweden.
- Department of Surgical Sciences, Section of Otolaryngology and Head and Neck Surgery, Uppsala University, Uppsala, Sweden.
ORCID profiles: Krzysztof Piersiala, Lars-Olaf Cardell
Funding
- Cancerfonden
- Radiumhemmets Forskningsfonder
Cite
APA
Piersiala, K., Hjalmarsson, E., da Silva, P. F. N., Lagebro, V., Kolev, A., Starkhammar, M., Elliot, A., Marklund, L., Munck-Wikland, E., Margolin, G., Georén, S. K., & Cardell, L. O. (2023). Regulatory B cells producing IL‐10 are increased in human tumor draining lymph nodes. International Journal of Cancer, 153(4), 854-866. https://doi.org/10.1002/ijc.34555
Vancouver
Piersiala K, Hjalmarsson E, da Silva PFN, Lagebro V, Kolev A, Starkhammar M, et al. Regulatory B cells producing IL‐10 are increased in human tumor draining lymph nodes. International Journal of Cancer. 2023;153(4):854-866. doi:10.1002/ijc.34555
BibTeX
@article{Piersiala2023,
author = {Piersiala, Krzysztof and Hjalmarsson, Eric and da Silva, Pedro Farrajota Neves and Lagebro, Vilma and Kolev, Aeneas and Starkhammar, Magnus and Elliot, Alexandra and Marklund, Linda and Munck-Wikland, Eva and Margolin, Gregori and Georén, Susanna Kumlien and Cardell, Lars-Olaf},
title = {Regulatory B cells producing IL‐10 are increased in human tumor draining lymph nodes},
journal = {International Journal of Cancer},
year = {2023},
volume = {153},
number = {4},
pages = {854--866},
doi = {10.1002/ijc.34555}
}
EUVIMED